NPPB and cardiac hypertrophy: Nx-Ob-ZSF1 Vehicle rats had significantly higher plasma NT-proBNP (a marker of cardiac hypertrophy) than Ln-ZSF1 rats, which was significantly reduced by FG-2216 treatment (Fig 8B).